Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia
Journal of Experimental Biology and Agricultural Sciences
; 9(2):131-137, 2021.
Article
in English
| Scopus | ID: covidwho-1404144
ABSTRACT
Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection. © 2021, Editorial board of Journal of Experimental Biology and Agricultural Sciences. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Case report
Country/Region as subject:
South America
/
Colombia
Language:
English
Journal:
Journal of Experimental Biology and Agricultural Sciences
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS